As previously reported, GOLM1 has been identified as a leading gene associated with cancer metastasis; it is supposed that GP73 serves as a potential drug target in therapeutics of metastatic cancers (17). This evidence concerns the gene GOLM1 and metastatic malignant neoplasm.